Partial response of a rare malignant metastatic diffuse tenosynovial giant cell tumor with benign histologic features, treated with SCH 717-454, an insulin growth factor receptor inhibitor, in combination with everolimus, an MTOR inhibitor
- Swati Sikaria
- , Josefine Heim-Hall
- , Elizabeth H. Diaz
- , Ronald Williams
- , Kamelesh Sankhala
- , Brenda Laabs
- , Monica Mita
Research output: Contribution to journal › Article › peer-review
7
Link opens in a new tab
Scopus
citations